Delhi High Court allows Indian biopharma companies to manufacture cheaper anti-cancer drugs

The Delhi High Court directed Biocon and Reliance Life Sciences to follow regulatory guidelines for making biosimilars

from IBTimes.co.in : Science http://ift.tt/1VPLVnW